Get access

Outcomes among patients treated for gastric adenocarcinoma during the last decade

Authors


  • The authors state that there is no disclosures or any affiliations for any of the authors.

Abstract

Objectives

To evaluate the outcomes among patients treated for gastric adenocarcinoma in a referral hospital, and to identify possible trends during the last decade.

Methods

All patients evaluated for gastric adenocarcinoma during the period 1999–2009 were included.

Results

Of 397 patients, 52% were curatively resected. Crude 5-year survival for the first 6 years period was 38.7% (CI 29.5–47.9), for the last 5 years, 49.2% (CI 38.8–59.6). Time period (P = 0.013), age (P < 0.001) and disease stage (P < 0.001), were significant predictors of long-term survival rates. Among curatively resected, in-hospital mortality was reduced from 8.5% in the first period to 2.0% in the last one (P = 0.037). There was a significant increase in the use of primary stents from the first to the last period (P = 0.006), paralleled by a significant reduction in the number of explorative laparotomies or bypass procedures (P < 0.001).

Conclusions

During the last decade, long-term survival rates improved among patients curatively resected for gastric adenocarcinoma, and in-hospital mortality was substantially reduced. For patients in a non-curative situation, there was a significant shift from explorative laparotomies or bypass procedures to primary use of stents. J. Surg. Oncol. 2013;107:752–757. © 2013 Wiley Periodicals, Inc.

Ancillary